Boit C.F. David’s Zimmer Biomet ZBH Stock Holding History

Boit C.F. David’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,500	Closed	-$136K	–	114
2026 Q1	$136K	Hold	1,500	–	–	0.06%	92
2025 Q4	$139K	Hold	1,500	–	–	0.06%	92
2025 Q3	$148K	Hold	1,500	–	–	0.07%	90
2025 Q2	$137K	Sell	1,500 -800	-35%	-$77.4K	0.07%	91
2025 Q1	$260K	Hold	2,300	–	–	0.13%	80
2024 Q4	$243K	Hold	2,300	–	–	0.1%	83
2024 Q3	$243K	Hold	2,300	–	–	0.12%	83
2024 Q2	$250K	Hold	2,300	–	–	0.13%	80
2024 Q1	$275K	Hold	2,300	–	–	0.15%	73
2023 Q4	$277K	Buy	2,300 +1,500	+188%	+$167K	0.16%	76
2023 Q3	$89.1K	Hold	800	–	–	0.06%	80
2023 Q2	$116K	Hold	800	–	–	0.08%	78
2023 Q1	$110K	Hold	800	–	–	0.08%	77
2022 Q4	$102K	Hold	800	–	–	0.07%	79
2022 Q3	$84K	Buy	+800	New	+$87.8K	0.07%	82
2022 Q1	$102K	Sell	800 -24	-3%	-$2.89K	0.07%	81
2021 Q4	$102K	Hold	824	–	–	0.06%	88
2021 Q3	$120K	Buy	+824	New	+$121K	0.08%	81

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boit C.F. David's ZBH Position: Q2 2026 in Review

Boit C.F. David sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 1,500 shares — an estimated $136K sold.

Boit C.F. David first reported a position in ZBH in Q3 2021 and held it in 18 quarters. The position peaked at $277K in Q4 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Boit C.F. David reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Boit C.F. David sold 1,500 Zimmer Biomet shares in Q2 2026, an estimated $136K.
Boit C.F. David first reported a position in Zimmer Biomet in Q3 2021 and held it in 18 quarters.
Boit C.F. David's Zimmer Biomet position peaked at $277K in Q4 2023.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Boit C.F. David's 13F filing for Q2 2026, filed 30 Jul 2026.